These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1356520)
1. Ethical difficulties with randomized clinical trials involving cancer patients: examples from the field of gynecologic oncology. Markman M J Clin Ethics; 1992; 3(3):193-5. PubMed ID: 1356520 [No Abstract] [Full Text] [Related]
2. A response to a purported ethical difficulty with randomized clinical trials involving cancer patients. Freedman B J Clin Ethics; 1992; 3(3):231-4. PubMed ID: 1392047 [No Abstract] [Full Text] [Related]
3. Ethical issues in cancer clinical trials. Kardinal CG J La State Med Soc; 1994 Aug; 146(8):359-61. PubMed ID: 7930868 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of advanced ovarian cancer: current status and future directions. Ozols RF; Vermorken JB Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-1-S2-9. PubMed ID: 9045324 [TBL] [Abstract][Full Text] [Related]
5. [Gynecologic cancer]. Uehara T; Katsumata N Gan To Kagaku Ryoho; 2008 Sep; 35(9):1488-94. PubMed ID: 18799902 [TBL] [Abstract][Full Text] [Related]
7. Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates. McGuire WP J Clin Oncol; 2009 Oct; 27(28):4633-4. PubMed ID: 19704055 [No Abstract] [Full Text] [Related]
8. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166 [No Abstract] [Full Text] [Related]
9. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer. Ozols RF Semin Oncol; 2000 Jun; 27(3 Suppl 7):3-7. PubMed ID: 10952119 [TBL] [Abstract][Full Text] [Related]
10. Carboplatin versus cisplatin in ovarian cancer. Alberts DS Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869 [TBL] [Abstract][Full Text] [Related]
11. Human experimentation and clinical trials [correction of trails]. Rosner F Isr J Med Sci; 1995 Sep; 31(9):580-2. PubMed ID: 7558787 [No Abstract] [Full Text] [Related]
12. [The role of paclitaxel in the first line treatment of cancer of the ovary?]. Slimane K Bull Cancer; 2003 Mar; 90(3):202-3. PubMed ID: 12803089 [No Abstract] [Full Text] [Related]
13. Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study. Greer BE; Bundy BN; Ozols RF; Fowler JM; Clarke-Pearson D; Burger RA; Mannel R; DeGeest K; Hartenbach EM; Baergen RN; Copeland LJ Gynecol Oncol; 2005 Oct; 99(1):71-9. PubMed ID: 16039699 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy in epithelial ovarian cancer. Wang J; Li AJ; Karlan BY Curr Womens Health Rep; 2002 Feb; 2(1):20-6. PubMed ID: 12112979 [TBL] [Abstract][Full Text] [Related]
15. [Choice of first-line chemotherapy for advanced ovarian cancer]. Tiuliandin SA Vopr Onkol; 1999; 45(4):350-4. PubMed ID: 10532090 [No Abstract] [Full Text] [Related]
16. Recent advances in the management of women with ovarian cancer. Eltabbakh GH Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412 [TBL] [Abstract][Full Text] [Related]
17. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study. ; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475 [TBL] [Abstract][Full Text] [Related]